Abstract：Objective To investigate the influence of down-regulation NEK-2 level on the radiosensitivity of A549 cells. Methods NEK-2 siRNA was transfected to A549 cells with liposome and NEK-2 expression level was inspected by Western blot. The radiosensitivity was detected by clone formation experiment. Cell cycle and cell apoptosis were analyzed by flow cytometry. Immunofluorescence experiment was used to detect the DNA double strand break and repair. Results NEK-2 siRNA successfully suppressed NEK-2 expression in A549 cells and resuced the cell proliferation ability after irradiation compared to the blank control group and the negative control group. It can improve the radiosensitivity of A549 cells (The radiosensitivity of A549 cells enhanced significantly.).The D0 values declined form 1.80 Gy to 1.40 Gy,and the sensitizing enhancement ratio was 1.32.After irradiation,compared to negative control group,the apoptosis rate was significantly improved (7.85% to 17.17%),cells in G2/M phase were obviously increased (9.23% to 30.16%),the DNA double strand break rate was increased (100% to 165%) and the DNA damage repair rate was reduced (100% to 48%) in NEK-2 siRNA group. The comparisons among the groups wer statistically significant (P<0.05). Conclusions NEK-2 siRNA reduced the proliferation and increased the radiosensitivity of A549 cell line,probably by affecting the cell cycle,promoting cell apoptosis and suppressing DNA damage repair.
Chen Chenglong,Peng Yiru,Zhang Nan et al. Effect of down-regulation NEK-2 level on radio-sensitibity of A549 cells[J]. Chinese Journal of Radiation Oncology, 2019, 28(2): 131-135.
[1] Chen W,Zheng R,Baade PD,et al. Cancer statistics in China,2015[J].Ca A Cancer J Clinicians,2016,66(2):115.DOI:10.3322/caac.21338. [2] 施世明,何健,黄艳,等.立体定向放疗治疗老年Ⅰ期肺癌的不良反应和疗效观察[J].复旦学报(医学版),2016,43(2):188-194.DOI:10.3969/j.issn.1672-8467.2016.02.011. Shi SM,He J,Huang Y,et al. Stereotactic body radiotherapy for elderly patients with stageⅠlung cancer:toxicity and effectiveness[J].Fudan Univ J Med Sci,2016,43(2):188-194.DOI:10.3969/j.issn.1672-8467.2016.02.011. [3] Zagryazhskaya A,Gyuraszova K,Zhivotovsky B.Cell death in cancer therapy of lung adenocarcinoma[J].Int J Develop Biol,2015,59(1-3):119.DOI:10.1387/ijdb.150044bz. [4] Pan D,Wang B,Zhou X,et al. Clinical study on gefitinib combined with γ-ray stereotactic body radiation therapy as the first-line treatment regimen for senile patients with adenocarcinoma of the lung (final results of JLY20080085)[J].Mol Clin Oncol,2013,1(4):711-715. DOI:10.3892/mco.2013.135. [5] Zhong X,Guan X,Liu W,et al. Aberrant expression of NEK-2 and its clinical significance in non-small cell lung cancer[J].Oncol Lett,2014,8(4):1470.DOI:10.3892/ol.2014.2396. [6] Zhong X,Guan X,Dong Q,et al. Examining NEK-2 as a better proliferation marker in non-small cell lung cancer prognosis[J].Int Soc Oncol Develop Biol Med,2014,35(7):7155-7162.DOI:10.1007/s13277-014-1935-8. [7] Jaehyung Lee LG.Mitotic perturbations induced by NEK-2 overexpression require interaction with TRF1 in breast cancer cells[J].Cell Cycle,2013,12(23):3599-3614.DOI:10.4161/cc.26589. [8] Ning Z,Wang A,Liang J,et al. Abnormal expression of NEK-2 in pancreatic ductal adenocarcinoma:a novel marker for prognosis[J].Int J Clin Exper Pathol,2014,7(5):2462.DOI:10.1007/s11899-014-0223-4. [9] Gang L,Zhong Y,Shen Q,et al. NEK-2 serves as a prognostic biomarker for hepatocellular carcinoma[J].Int J Oncol,2017,50(2):405-413.DOI:10.3892/ijo.2017.3837. [10] 赵海波,吴永定,梁宇翔,et al.miR-195调控NEK-2对前列腺癌细胞增殖的影响[J].广东医学,2017,38(7):1002-1004. Zhao HB,Wu YD,Liang YX, et al. Effect of miR-195 on the proliferation of prostate cancer cells by NEK-2[J].Guangdong Med J,2017,38(7):1002-1004. [11] 何云,黄璀.下调NEK-2表达对肾癌细胞侵袭、迁移的影响[J].山东医药,2017,57(14):45-47.DOI:10.3969/j.issn.1002-266X.2017.14.011. He Y,Huang C.Down-regulation of NEK-2 expression on invasion and migration of renal cancer cells[J].Shandong Med J,2017,57(14):45-47.DOI:10.3969/j.issn.1002-266X.2017.14.011. [12] 陈浩,马洪,段晓峰,等.NEK-2基因在口腔鳞状细胞癌中的表达及意义[J].实用口腔医学杂志,2016,32(3):436-438. Chen H,Ma H,Duan XF, et al. The expression and significance of NEK2 Mrna in oral squamouse cell carcinoma[J].J Pract Stomatol,2016,32(3):436-438. [13] Naro C,Barbagallo F,Chieffi P,et al. The centrosomal kinase NEK-2 is a novel splicing factor kinase involved in cell survival[J].Nucl Aci Res,2014,42(5):3218-3227.DOI:10.1093/nar/gkt1307. [14] Hu CM,Zhu J,Guo XE,et al. Novel small molecules disrupting Hec1/NEK-2 interaction ablate tumor progression by triggering NEK-2 degradation through a death-trap mechanism[J].Oncogene,2015,34(10):1220.DOI:10.1038/onc.2014.67. [15] Kokuryo T,Hibino S,Suzuki K,et al. NEK-2 siRNA therapy using a portal venous port–catheter system for liver metastasis in pancreatic cancer[J].Cancer Science,2016,107(9):1315.DOI:10.1111/cas.12993. [16] Kokuryo T,Senga T,Yokoyama Y,et al. NEK-2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma[J].Cancer Res,2007,67(20):9637-9642.DOI:10.1158/0008-5472.CAN-07-1489. [17] 范婷婷,唐良萏.NEK-2基因沉默对卵巢癌SKOV3细胞侵袭能力的影响[J].第三军医大学学报,2012,34(15):1514-1517. Fan TT,Tang LD. Effect of NEK-2 gene silencing on invasion ability of ovarian cancer SKOV3 cells[J].J Third Mil Med Univ,2012,34(15):1514-1517. [18] 范婷婷,唐良萏.NEK-2基因沉默促进卵巢癌细胞SKOV3凋亡[J].基础医学与临床,2012,32(6):664-668. Fan TT,Tang LD.Promotion of apoptosis of ovarian cancer SKOV3 cells by silencing NEK2[J].Basic& Clinical Med,2012,32(6):664-668. [19] Fu SJ,Chen J,Ji F,et al. MiR-486-5p negatively regulates oncogenic NEK-2 in hepatocellular carcinoma[J].Oncotarget,2017,8(32):52948-52959.DOI:10.18632/oncotarget.17635. [20] Zhao D,Han W,Liu X,et al. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2[J].Thoracic Cancer,2017,8(4):320-327.DOI:10.1111/1759-7714.12444. [21] Liu H,Liu B,Hou X,et al. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma[J].J Neuro-oncol,2017,132(3):1-9.DOI:10.1007/s11060-017-2401-4. [22] Wang J,Cheng P,Pavlyukov MS,et al. Targeting NEK-2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2[J].J Clin Investi,2017,127(8):3075-3089. DOI:10.1172/JCI89092.
2019, Vol. 28 
